NYSE - Delayed Quote • USD
West Pharmaceutical Services, Inc. (WST)
At close: May 31 at 4:00 PM EDT
After hours: May 31 at 6:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 1.74 | 2.14 | 7.76 | 9.08 |
| Low Estimate | 1.54 | 2.06 | 7.63 | 8.31 |
| High Estimate | 1.94 | 2.19 | 8.13 | 9.5 |
| Year Ago EPS | 2.11 | 2.16 | 8.08 | 7.76 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 728.66M | 783.97M | 3.01B | 3.28B |
| Low Estimate | 705.26M | 775M | 3B | 3.25B |
| High Estimate | 745.2M | 790M | 3.02B | 3.33B |
| Year Ago Sales | 755.71M | 747.4M | 2.95B | 3.01B |
| Sales Growth (year/est) | -3.60% | 4.90% | 2.10% | 9.10% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.93 | 1.86 | 1.78 | 1.26 |
| EPS Actual | 2.11 | 2.16 | 1.83 | 1.56 |
| Difference | 0.18 | 0.3 | 0.05 | 0.3 |
| Surprise % | 9.30% | 16.10% | 2.80% | 23.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.74 | 2.14 | 7.76 | 9.08 |
| 7 Days Ago | 1.74 | 2.14 | 7.76 | 9.08 |
| 30 Days Ago | 1.74 | 2.14 | 7.74 | 9.04 |
| 60 Days Ago | 1.99 | 2.11 | 7.62 | 9.05 |
| 90 Days Ago | 1.98 | 2.1 | 7.61 | 9.05 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | WST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -17.50% | -- | -- | 8.90% |
| Next Qtr. | -0.90% | -- | -- | 11.40% |
| Current Year | -4.00% | -- | -- | 5.80% |
| Next Year | 17.00% | -- | -- | 12.60% |
| Next 5 Years (per annum) | 6.87% | -- | -- | 11.45% |
| Past 5 Years (per annum) | 22.16% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | UBS: Neutral to Neutral | 2/16/2024 |
| Maintains | Keybanc: Overweight to Overweight | 2/13/2024 |
| Upgrade | Jefferies: Hold to Buy | 2/7/2024 |
| Maintains | Stephens & Co.: Overweight to Overweight | 10/27/2023 |
| Maintains | Keybanc: Overweight to Overweight | 8/30/2023 |
| Maintains | Keybanc: Overweight to Overweight | 8/21/2023 |
Related Tickers
TFX Teleflex Incorporated
209.07
+1.18%
RMD ResMed Inc.
206.33
-1.44%
COO The Cooper Companies, Inc.
94.31
+4.52%
BDX Becton, Dickinson and Company
231.97
+2.29%
STVN Stevanato Group S.p.A.
20.32
+3.83%
RGEN Repligen Corporation
149.09
+0.61%
ALC Alcon Inc.
89.13
+0.88%
HOLX Hologic, Inc.
73.78
+1.65%
ATR AptarGroup, Inc.
147.69
+1.06%
ATRI Atrion Corporation
460.25
-0.44%